NCT05163821
Completed
Not Applicable
Pilot of a New Cognitive Assessment Tool for Detecting Dementia in the Migrant Somali Population
Greater Manchester Mental Health NHS Foundation Trust1 site in 1 country12 target enrollmentJanuary 8, 2022
ConditionsDementia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Dementia
- Sponsor
- Greater Manchester Mental Health NHS Foundation Trust
- Enrollment
- 12
- Locations
- 1
- Primary Endpoint
- Qualitative feedback on completing the cognitive screens
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Aims
- The investigators want to find out if the tool that they have made to assess memory and thinking in Somali elders ( the 'MSCAT') is acceptable to that community and practical to administer and score.
- The public will benefit from this research because it seeks to enhance reliability of diagnosis of dementia, thus access to support and treatment for people from an ethnic minority group experiencing memory problems.
Background
- The investigators are a group of staff from the Memory Assessment Service in Manchester. There are currently no suitable tests for dementia for people from Somalia.
- Research evidence tells us there are many reasons why the tools that used now are not working. This includes: differences in culture and ways of life that are very different to a British born person who has lived in the UK for all of their life.
- Somali people find out at a later stage if they have dementia resulting in delayed treatment/support.
- This research supports the government's promise to improve the pathway to a diagnosis of dementia for minority groups.
Design and methods
- 10 participants
- The investigators will compare the assessment tool (MSCAT) that the team have developed to the Addenbrookes Cognitive Examination III tool that is typically used.
- Participants will be seen at an agreed location (e.g. home, mosque or GMMH trust site). They will meet a Somali speaking researcher to do both tests on 2 appointments and discuss how they found the tests afterwards.
- The investigators will check participants understanding of the research before they agree to take part. Verbal and written information will be provided.
Public involvement
- The local Somali community helped advise on the creation of the new MSCAT assessment tool.
- The investigators will write project information for participants in Somali and English.
Dissemination of results
• Professional conference presentations and publications
Investigators
Sophie Jeffery
Principal Clinical Psychologist
Greater Manchester Mental Health NHS Foundation Trust
Eligibility Criteria
Inclusion Criteria
- •The participants will all be Somali-born migrants, over the age of 50, living in the UK.
Exclusion Criteria
- •Exclusion criteria will include the presence of dementia, current delirium, or inability to complete the tasks due to visual/hearing/physical impairment
Outcomes
Primary Outcomes
Qualitative feedback on completing the cognitive screens
Time Frame: Immediately after completing the screen
Interview
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Development of a Cognitive Tool for Rapid and Reliable Screening of Minimal Hepatic Encephalopathy: Pilot StudyHepatic Pathology (Fibrosis, Cirrhosis, Porto Systemic Shunts)NCT06619106Assistance Publique - Hôpitaux de Paris100
Completed
Not Applicable
Brief Assessment of Impaired CognitionDementiaNCT04304859Danish Dementia Research Centre428
Recruiting
Not Applicable
Development of an assessment tool and cognitive rehabilitation strategy for working memory impairment in schizophreniaschizophreniaJPRN-UMIN000009788ational Center Hospital, National Center of Neurology and Psychiatry64
Withdrawn
Not Applicable
Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention TrainingPediatric CancerNCT05000905University of California, San Francisco70
Unknown
Not Applicable
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's DiseaseAlzheimer DiseaseDementiaNeuropathologyMild Cognitive ImpairmentNCT03676881Bruyere Research Institute36